Publications by authors named "Sampada Dipak Bangar"
Recurrent Tuberculosis patients contribute to a significant proportion of TB burden in India. A nationwide survey was conducted during 2019-2021 across India among adults to estimate the prevalence of TB. A total of 322480 individuals were screened and 1402 were having TB.
View Article and Find Full Text PDFArticle Synopsis
- - The analysis aimed to determine the prevalence of tuberculosis (TB) infection in India, revealing that approximately 22.6% of the population over 15 years old is infected with TB.
- - Data from the National TB prevalence survey indicated that factors such as being over 30 years old, male gender, urban residency, and having a previous TB history are significantly associated with higher TB infection rates.
- - The study highlights the need for targeted interventions and monitoring to effectively address and reduce the high burden of TB in India.
Introduction: Individual and community characteristics predictive of knowledge, perception, and attitude on COVID-19, specifically on gender, have not been adequately explored.
Objective: To examine the gender differences in COVID-19 knowledge, self-risk perception and public stigma among the general community and to understand other socio-demographic factors which were predictive of them.
Method: A nationally representative cross-sectional multi-centric survey was conducted among adult individuals(≥18 yrs) from the community member (N = 1978) from six states and one union territory of India between August 2020 to February 2021.
Objective: To assess factors associated with COVID-19 stigmatizing attitudes in the community and stigma experiences of COVID-19 recovered individuals during first wave of COVID-19 pandemic in India.
Methods: A cross-sectional study was conducted in 18 districts located in 7 States in India during September 2020 to January 2021 among adults > 18 years of age selected through systematic random sampling. Data on socio demographic and COVID-19 knowledge were collected from 303 COVID-19 recovered and 1,976 non-COVID-19 infected individuals from community using a survey questionnaire.
Background & Objectives: COVID-19 pandemic has triggered social stigma towards individuals affected and their families. This study describes the process undertaken for the development and validation of scales to assess stigmatizing attitudes and experiences among COVID-19 and non-COVID-19 participants from the community.
Methods: COVID-19 Stigma Scale and Community COVID-19 Stigma Scale constituting 13 and six items, respectively, were developed based on review of literature and news reports, expert committee evaluation and participants' interviews through telephone for a multicentric study in India.
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
PLoS Med
December 2021
Background: India began COVID-19 vaccination in January 2021, initially targeting healthcare and frontline workers. The vaccination strategy was expanded in a phased manner and currently covers all individuals aged 18 years and above. India experienced a severe second wave of COVID-19 during March-June 2021.
View Article and Find Full Text PDFBackground: The first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in India, done in May-June, 2020, among adults aged 18 years or older from 21 states, found a SARS-CoV-2 IgG antibody seroprevalence of 0·73% (95% CI 0·34-1·13). We aimed to assess the more recent nationwide seroprevalence in the general population in India.
Methods: We did a second household serosurvey among individuals aged 10 years or older in the same 700 villages or wards within 70 districts in India that were included in the first serosurvey.
Article Synopsis
- The India Hypertension Control Initiative (IHCI) is a collaborative program aimed at controlling hypertension in India, involving 21,895 adult patients from four different states.
- A significant follow-up assessment revealed that blood pressure (BP) control improved from 26.3% to 59.8% among returning patients, indicating effective management, especially in primary care settings.
- Despite promising results, the initiative faced challenges with patient retention, highlighting the need for strategies to ensure more patients return for ongoing hypertension care.
Article Synopsis
- * A total of 28,000 individuals were tested for IgG antibodies, revealing a population-weighted seroprevalence of 0.73%, equating to approximately 6.47 million adult infections by early May.
- * Factors such as being male, residing in urban slums, and having high-risk occupations were linked to higher seropositivity, with an infection case ratio ranging from 81.6 to 130.1 and